KIF1A (Kinesin-like protein KIF1A) variants and mutations
KIF1A (also known as Kinesin-like protein KIF1A) is a human protein-coding gene encoding a kinesin-like protein. It transports synaptic vesicle precursors and other cargo along axonal microtubules toward nerve terminals. Pathogenic variants cause a broad KIF1A-associated neurological disorder spectrum including hereditary sensory neuropathy, spastic paraplegia, optic atrophy, ataxia, and developmental impairment. This analysis covers 560 KIF1A variants and mutations. Of these, 62% have computational variant effect predictions. Disease context includes intellectual disability, autosomal dominant 9, hereditary spastic paraplegia 30, and Autosomal recessive spastic paraplegia type 30. Example KIF1A variants include M1V, G3R, and V6L.
Variant analysis overview
- Gene: KIF1A
- Protein: Kinesin-like protein KIF1A
- UniProt accession: Q12756
- Organism: Homo sapiens
- Variants analyzed: 560
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 471 unspecified-consequence records; 1 stop retained variant; 1 stop lost; 63 missense variants; 16 synonymous variants; 1 frameshift variants; 1 splice-region variants; 4 stop-gained variants; 2 substitution
- Prediction scores: 350 variants have prediction scores (62% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: intellectual disability, autosomal dominant 9, hereditary spastic paraplegia 30, Autosomal recessive spastic paraplegia type 30, neuropathy, hereditary sensory, type 2C, spastic paraplegia 30A, autosomal dominant, hereditary sensory and autonomic neuropathy type 2, spastic paraplegia 30B, autosomal recessive, neurodegenerative disease, hereditary spastic paraplegia, hereditary disease, KIF1A related neurological disorder, Alzheimer disease.
Protein structure and variant hotspots
- Protein features: 3 domains; 6 binding sites; 14 post-translational modification sites.
- Structural context: 229 variants have structural context.
- PTM context: 6 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable KIF1A variants
Examples include M1V, G3R, V6L, V8A, R11Q, R11W, V12I, R13C. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1V (p.Met1Val), rs1559538947, ClinGen CA351316207, ClinVar RCV000712144, MetaLR 0.51, MetaSVM 0.12, Uncertain significance, not provided
- G3R (p.Gly3Arg), rs751960710, ClinGen CA2208926, NCI-TCGA Cosmic COSV5749, cosmic curated COSV57494, REVEL 0.54, CADD 25.10, Uncertain significance, Inborn genetic diseases; Hereditary spastic paraplegia 30; Neuropathy, hereditar
- V6L (p.Val6Leu), rs2538657193, ClinGen CA351316108, ClinVar RCV003805720, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- V8A (p.Val8Ala), rs2538656995, ClinGen CA351316043, ClinVar RCV003785297, ClinVar RCV006437226, Uncertain significance, not provided; Neuropathy, hereditary sensory, type 2C; Hereditary spastic parapl
- R11Q (p.Arg11Gln), rs1575654528, ClinGen CA351315977, NCI-TCGA Cosmic COSV5748, cosmic curated COSV57483, REVEL 0.97, CADD 28.30, Pathogenic/Likely pathogenic, Intellectual disability, autosomal dominant 9; Hereditary spastic paraplegia 30
- R11W (p.Arg11Trp), rs548204329, ClinGen CA68147204, cosmic curated COSV10942, ClinVar RCV000515907, REVEL 0.90, CADD 30.00, Pathogenic/Likely pathogenic, Hereditary spastic paraplegia 30; Inborn genetic diseases; Neuropathy, hereditar
- V12I (p.Val12Ile), rs2538656538, ClinGen CA351315961, ClinVar RCV003798195, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- R13C (p.Arg13Cys), UniProt VAR 086844, Pathogenic/Likely pathogenic, Hereditary spastic paraplegia 30; Intellectual disability, autosomal dominant 9
- R13H (p.Arg13His), rs797045050, ClinGen CA250361, cosmic curated COSV57487, ClinVar RCV000191098, REVEL 0.95, CADD 28.80, Pathogenic/Likely pathogenic, Spastic paraplegia; Intellectual disability, autosomal dominant 9; Hereditary sp
- P14L (p.Pro14Leu), rs879253976, ClinGen CA10584200, NCI-TCGA Cosmic COSV1002, AlphaMissense 0.97, MetaLR 0.97, Conflicting interpretations, Hereditary spastic paraplegia; not provided; Intellectual disability
- R18W (p.Arg18Trp), rs2056556566, ClinGen CA351315874, NCI-TCGA Cosmic COSV5750, cosmic curated COSV57500, REVEL 0.85, CADD 27.90, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- R22C (p.Arg22Cys), rs767331601, ClinGen CA2208919, NCI-TCGA Cosmic COSV5749, cosmic curated COSV57494, REVEL 0.61, CADD 29.20, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- M30T (p.Met30Thr), UniProt VAR 083688, Uncertain significance, Hereditary spastic paraplegia 30
- T35A (p.Thr35Ala), rs2538654464, ClinGen CA351315403, ClinVar RCV003792212, REVEL 0.82, CADD 26.60, Likely pathogenic, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- T35S (p.Thr35Ser), rs2056551129, ClinGen CA351315388, ClinVar RCV003218887, AlphaMissense 0.97, MetaLR 0.83, Uncertain significance, not provided
- V38I (p.Val38Ile), rs2538463288, ClinGen CA351311834, ClinVar RCV002659467, ClinVar RCV005639429, REVEL 0.26, CADD 7.61, Uncertain significance, not provided; Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory
- E45A (p.Glu45Ala), rs2538462914, ClinGen CA351311781, ClinVar RCV003282547, REVEL 0.49, CADD 27.60, Uncertain significance, Inborn genetic diseases
- E45Q (p.Glu45Gln), rs549637772, ClinGen CA351311785, ClinVar RCV002775100, AlphaMissense 0.80, MetaLR 0.26, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- T46M (p.Thr46Met), rs182395595, ClinGen CA2208894, cosmic curated COSV57493, ClinVar RCV001143665, REVEL 0.30, CADD 24.60, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- K48E (p.Lys48Glu), rs2538462644, ClinGen CA351311767, ClinVar RCV004531654, Likely pathogenic, KIF1A-related disorder
- S49N (p.Ser49Asn), rs2538462517, ClinGen CA351311756, ClinVar RCV003802695, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- Y54D (p.Tyr54Asp), UniProt VAR 086846, Uncertain significance, in KAND
- Y56C (p.Tyr56Cys), UniProt VAR 083689, Uncertain significance, Hereditary spastic paraplegia 30
- W57* (p.Trp57Ter), rs1394063648, gnomAD 2-240719802-C-T, REVEL 0.09, CADD 21.50
- S58L (p.Ser58Leu), rs672601362, ClinGen CA212612, cosmic curated COSV10024, ClinVar RCV000149474, AlphaMissense 0.94, MetaLR 0.64, Pathogenic, Spastic paraplegia 30A, autosomal dominant; Inborn genetic diseases; Hereditary
- S61L (p.Ser61Leu), rs2126098498, ClinGen CA351311666, NCI-TCGA Cosmic COSV5750, cosmic curated COSV57501, AlphaMissense 0.09, MetaLR 0.34, Uncertain significance, not provided; Hereditary spastic paraplegia; Intellectual disability, autosomal
- Y67* (p.Tyr67Ter), rs2538439290, ClinGen CA2580068121, ClinVar RCV002867284, Pathogenic
- A68T (p.Ala68Thr), rs761950783, ClinGen CA2208853, ClinVar RCV001204886, ClinVar RCV002418679, REVEL 0.70, CADD 25.50, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- S69L (p.Ser69Leu), rs786200949, ClinGen CA351310990, ClinVar RCV001391592, UniProt VAR 077467, AlphaMissense 0.26, MetaLR 0.70, Pathogenic/Likely pathogenic, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- Y74C (p.Tyr74Cys), rs2055191530, ClinGen CA351310888, ClinVar RCV001251236, ClinVar RCV006557251, AlphaMissense 0.67, MetaLR 0.91, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- R75K (p.Arg75Lys), rs202164471, gnomAD 2-240719785-C-T, CADD 7.96
- G78S (p.Gly78Ser), UniProt VAR 083691, REVEL 0.89, CADD 25.80, Pathogenic/Likely pathogenic, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- E80G (p.Glu80Gly), rs2538438133, ClinGen CA351310740, ClinVar RCV002293857, Uncertain significance, not provided
- M81T (p.Met81Thr), rs2538438103, ClinGen CA351310719, ClinVar RCV003817899, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- L82P (p.Leu82Pro), rs201119646, gnomAD 2-240719797-A-G, CADD 1.87
- Y89D (p.Tyr89Asp), rs869312711, ClinGen CA353415, ClinVar RCV000209842, UniProt VAR 086847, AlphaMissense 0.98, MetaLR 0.91, Pathogenic, Intellectual disability, autosomal dominant 9
- Y89F (p.Tyr89Phe), rs2538437589, ClinGen CA351310480, ClinVar RCV002805730, REVEL 0.84, CADD 26.20, Likely pathogenic, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- C92R (p.Cys92Arg), UniProt VAR 086848, Pathogenic, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- C92Y (p.Cys92Tyr), rs2538437439, ClinGen CA351310429, ClinVar RCV003327077, REVEL 0.87, CADD 26.50, Pathogenic, not provided
- I93N (p.Ile93Asn), rs767502189, ClinGen CA351310404, ClinVar RCV003800668, AlphaMissense 0.99, MetaLR 0.76, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- T99M (p.Thr99Met), rs387906799, ClinGen CA212601, ClinVar RCV000023087, ClinVar RCV000207102, AlphaMissense 0.99, MetaLR 0.84, Pathogenic, PEHO syndrome; Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory
- A101V (p.Ala101Val), rs2126091776, ClinGen CA351310258, ClinVar RCV003153103, REVEL 0.76, CADD 26.70, Likely pathogenic, Hereditary spastic paraplegia 30
- G102D (p.Gly102Asp), rs672601363, ClinGen CA212615, ClinVar RCV000149475, UniProt VAR 075473, REVEL 0.98, CADD 26.10, Likely pathogenic, Intellectual disability, autosomal dominant 9
- G102S (p.Gly102Ser), rs1064795534, ClinGen CA16617512, ClinVar RCV000487011, ClinVar RCV000534578, REVEL 0.97, CADD 26.50, Pathogenic/Likely pathogenic, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- K103T (p.Lys103Thr), UniProt VAR 086849, Pathogenic, not provided
- S104* (p.Ser104Ter), gnomAD 2-240719776-G-T, CADD 15.20
- S104Y (p.Ser104Tyr), rs767301813, gnomAD 2-240719782-G-T, CADD 7.93
- S104F (p.Ser104Phe), rs2045069336, gnomAD 2-240719800-G-A, CADD 4.14
- T106N (p.Thr106Asn), UniProt VAR 083692, Likely pathogenic, Hereditary spastic paraplegia 30
- M108K (p.Met108Lys), rs2055180415, ClinGen CA351310133, ClinVar RCV003044483, REVEL 0.92, CADD 27.30, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- G109R (p.Gly109Arg), rs2538436392, ClinGen CA351310119, ClinVar RCV003057659, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- G117V (p.Gly117Val), rs1200817308, ClinGen CA351309985, ClinVar RCV000624693, UniProt VAR 086850, REVEL 0.89, CADD 32.00, Pathogenic, Inborn genetic diseases
- I118N (p.Ile118Asn), rs2538435708, ClinGen CA351309976, ClinVar RCV003805732, REVEL 0.92, CADD 29.40, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- L122P (p.Leu122Pro), rs2538415092, ClinGen CA351309687, ClinVar RCV003803339, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- E124K (p.Glu124Lys), rs1237269969, ClinGen CA351309641, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, REVEL 0.63, CADD 23.10, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- R129W (p.Arg129Trp), rs868067075, ClinGen CA68141955, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, REVEL 0.62, CADD 27.50, Conflicting interpretations, Inborn genetic diseases; Hereditary spastic paraplegia 30; Neuropathy, hereditar
- N131I (p.Asn131Ile), rs2538414365, ClinGen CA351309420, ClinVar RCV003378864, Uncertain significance, Inborn genetic diseases
- D132A (p.Asp132Ala), rs2538414211, ClinGen CA351309370, ClinVar RCV003806302, REVEL 0.24, CADD 21.80, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- T134A (p.Thr134Ala), rs2538414054, ClinGen CA351309290, ClinVar RCV003798244, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- D136N (p.Asp136Asn), rs374178011, ClinGen CA2208796, cosmic curated COSV57498, ClinVar RCV001585068, REVEL 0.18, CADD 16.90, Uncertain significance, Hereditary spastic paraplegia; Inborn genetic diseases; Hereditary spastic parap
- V142M (p.Val142Met), rs745504142, ClinGen CA2208789, NCI-TCGA Cosmic COSV5748, cosmic curated COSV57486, REVEL 0.76, CADD 24.90, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- V144F (p.Val144Phe), rs672601364, ClinGen CA212618, ClinVar RCV000149476, ClinVar RCV006450026, AlphaMissense 0.98, MetaLR 0.62, Likely pathogenic, Spastic paraplegia 30A, autosomal dominant; Intellectual disability, autosomal d
- E148D (p.Glu148Asp), UniProt VAR 083693, Likely pathogenic, Intellectual disability, autosomal dominant 9
- E148K (p.Glu148Lys), UniProt VAR 086851, Likely pathogenic, not provided
- I149V (p.Ile149Val), rs2538354707, ClinGen CA351307117, ClinVar RCV003332438, Uncertain significance, not provided
- C151Y (p.Cys151Tyr), UniProt VAR 086852, Conflicting interpretations, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- R153H (p.Arg153His), rs750829308, ClinGen CA2208758, NCI-TCGA Cosmic COSV1002, NCI-TCGA Cosmic COSV5748, REVEL 0.70, CADD 26.50, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- V154I (p.Val154Ile), rs757821128, ClinGen CA351306903, ClinVar RCV002342445, REVEL 0.43, CADD 24.40, Uncertain significance, Inborn genetic diseases
- R155C (p.Arg155Cys), rs1434341247, ClinGen CA351306864, NCI-TCGA Cosmic COSV5748, cosmic curated COSV57485, REVEL 0.84, CADD 28.50, Uncertain significance, Intellectual disability, autosomal dominant 9; Neuropathy, hereditary sensory, t
- R155H (p.Arg155His), rs2538354351, ClinGen CA351306837, ClinVar RCV002305098, ClinVar RCV006275115, REVEL 0.85, CADD 26.60, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- D156V (p.Asp156Val), UniProt VAR 086854, Pathogenic, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- L157H (p.Leu157His), UniProt VAR 086855, Uncertain significance, in KAND
- N159H (p.Asn159His), rs2538354015, ClinGen CA351306728, ClinVar RCV003319657, Uncertain significance, not provided
- K161T (p.Lys161Thr), rs1011045689, ClinGen CA351306645, ClinVar RCV002750718, ClinVar RCV002774781, AlphaMissense 0.90, MetaLR 0.82, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- R167C (p.Arg167Cys), rs672601365, ClinGen CA212621, NCI-TCGA Cosmic COSV5748, cosmic curated COSV57488, REVEL 0.92, CADD 28.40, Pathogenic/Likely pathogenic, Spastic paraplegia 30A, autosomal dominant; Hereditary spastic paraplegia 30; Ne
- R167H (p.Arg167His), rs2054757914, ClinGen CA351306501, ClinVar RCV001251216, ClinVar RCV001879816, REVEL 0.75, CADD 25.50, Pathogenic/Likely pathogenic, not provided; Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory
- H171P (p.His171Pro), rs876661180, ClinGen CA10577245, ClinVar RCV000223418, UniProt VAR 086856, AlphaMissense 0.97, MetaLR 0.84, Pathogenic, not provided
- L173P (p.Leu173Pro), UniProt VAR 083695, Likely pathogenic, Inborn genetic diseases; Hereditary spastic paraplegia 30
- Y177D (p.Tyr177Asp), rs2538352230, ClinGen CA351306197, ClinVar RCV003235837, Uncertain significance, not provided
- E179G (p.Glu179Gly), rs879253948, ClinGen CA10584199, ClinVar RCV000237085, ClinVar RCV003765471, AlphaMissense 0.94, MetaLR 0.55, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- V186F (p.Val186Phe), UniProt VAR 083696, Likely pathogenic, Intellectual disability, autosomal dominant 9
- T187I (p.Thr187Ile), rs370623844, ClinGen CA2208750, ClinVar RCV000502672, ClinVar RCV001066424, REVEL 0.54, CADD 24.30, Uncertain significance, Inborn genetic diseases; not specified; Hereditary spastic paraplegia 30
- M196T (p.Met196Thr), rs2538350980, ClinGen CA351305568, ClinVar RCV002942669, REVEL 0.86, CADD 26.40, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- G199E (p.Gly199Glu), UniProt VAR 086858, Uncertain significance, in KAND
- G199R (p.Gly199Arg), UniProt VAR 083697, Pathogenic/Likely pathogenic, Autosomal dominant non-syndromic intellectual disability; Intellectual disabilit
- A202P (p.Ala202Pro), rs672601366, ClinGen CA212624, ClinVar RCV000149478, UniProt VAR 075478, AlphaMissense 0.99, MetaLR 0.53, Likely pathogenic, Intellectual disability, autosomal dominant 9
- R203S (p.Arg203Ser), UniProt VAR 086859, Uncertain significance, in KAND
- T204N (p.Thr204Asn), rs2126062797, ClinGen CA351305036, ClinVar RCV002360264, AlphaMissense 0.97, MetaLR 0.51, Uncertain significance, Inborn genetic diseases
- V205M (p.Val205Met), rs371039513, UniProt VAR 075479, ESP rs371039513, ExAC rs371039513, REVEL 0.74, CADD 24.30
- A206V (p.Ala206Val), rs750125764, cosmic curated COSV57499, UniProt VAR 086860, ExAC rs750125764, REVEL 0.83, CADD 25.70, Uncertain significance, in KAND
- M210I (p.Met210Ile), rs2538309429, ClinGen CA351304903, ClinVar RCV003152912, Likely pathogenic, Hereditary spastic paraplegia 30
- M210T (p.Met210Thr), UniProt VAR 086861, Uncertain significance, in KAND
- N211D (p.Asn211Asp), rs2538309390, ClinGen CA351304895, ClinVar RCV003883385, Pathogenic, Neuropathy, hereditary sensory and autonomic, type 2A; Hereditary spastic parapl
- N211H (p.Asn211His), UniProt VAR 086862, Pathogenic, not provided
- N211K (p.Asn211Lys), rs2054552679, ClinGen CA351304881, ClinVar RCV002999932, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- S214N (p.Ser214Asn), UniProt VAR 086863, Likely pathogenic, Inborn genetic diseases
- S215R (p.Ser215Arg), rs672601367, ClinGen CA212627, ClinVar RCV000149479, ClinVar RCV001090762, AlphaMissense 1.00, MetaLR 0.88, Pathogenic, not provided; Intellectual disability, autosomal dominant 9; Hereditary spastic
- R216C (p.Arg216Cys), rs797045164, ClinGen CA204974, NCI-TCGA Cosmic COSV5748, cosmic curated COSV57482, AlphaMissense 1.00, MetaLR 0.89, Pathogenic/Likely pathogenic, Spastic paraplegia 30A, autosomal dominant; not provided; PEHO syndrome
- R216H (p.Arg216His), rs672601368, ClinGen CA204977, NCI-TCGA Cosmic COSV5748, cosmic curated COSV57482, AlphaMissense 0.99, MetaLR 0.89, Pathogenic/Likely pathogenic, PEHO syndrome; Intellectual disability, autosomal dominant 9; not provided
- R216P (p.Arg216Pro), rs672601368, UniProt VAR 075483, AlphaMissense 0.99, MetaLR 0.89, Conflicting interpretations, Intellectual disability, autosomal dominant 9
- S217F (p.Ser217Phe), rs876661202, ClinGen CA351304762, ClinVar RCV001329211, ClinVar RCV005411720, AlphaMissense 0.97, MetaLR 0.90, Conflicting interpretations, not provided; Intellectual disability, autosomal dominant 9
- S217Y (p.Ser217Tyr), UniProt VAR 086864, Uncertain significance, in KAND
- A219D (p.Ala219Asp), rs2538308626, ClinGen CA351304731, ClinVar RCV003817972, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- V220I (p.Val220Ile), rs201314877, ClinGen CA2208711, ClinVar RCV000639775, ClinVar RCV001662688, REVEL 0.43, CADD 24.40, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- R229C (p.Arg229Cys), rs776660768, ClinGen CA2208707, ClinVar RCV001042660, UniProt VAR 086865, REVEL 0.46, CADD 24.90, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- E233D (p.Glu233Asp), rs373882732, ClinGen CA2208702, ClinVar RCV000695006, ClinVar RCV002369880, REVEL 0.25, CADD 20.10, Conflicting interpretations, Inborn genetic diseases; Neuropathy, hereditary sensory, type 2C; Intellectual d
- T237I (p.Thr237Ile), rs2538307391, ClinGen CA351304500, ClinVar RCV002700387, ClinVar RCV003235737, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- E239K (p.Glu239Lys), UniProt VAR 090133, REVEL 0.79, CADD 27.40, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- V241L (p.Val241Leu), rs1020913034, ClinGen CA351303436, ClinVar RCV003796556, REVEL 0.67, CADD 33.00, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- V247A (p.Val247Ala), rs2538277955, ClinGen CA351303308, ClinVar RCV002705860, REVEL 0.84, CADD 29.20, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- V247M (p.Val247Met), rs2538278006, ClinGen CA351303329, ClinVar RCV003133875, ClinVar RCV004765757, REVEL 0.80, CADD 26.60, Conflicting interpretations, not provided
- D248E (p.Asp248Glu), UniProt VAR 086867, Uncertain significance, in KAND
- D248G (p.Asp248Gly), UniProt VAR 086868, Uncertain significance, in KAND
- L249Q (p.Leu249Gln), rs672601371, ClinGen CA212639, ClinVar RCV000149483, UniProt VAR 075486, AlphaMissense 1.00, MetaLR 0.96, Likely pathogenic, Intellectual disability, autosomal dominant 9
- G251E (p.Gly251Glu), rs2538277557, ClinGen CA351303203, ClinVar RCV003988912, REVEL 0.94, CADD 25.50, Uncertain significance, Intellectual disability, autosomal dominant 9
- G251R (p.Gly251Arg), rs2538277599, ClinGen CA351303208, ClinVar RCV003030819, UniProt VAR 086869, Pathogenic, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- S252R (p.Ser252Arg), UniProt VAR 083698, REVEL 0.73, CADD 13.00, Conflicting interpretations, Hereditary spastic paraplegia 30; Inborn genetic diseases
- E253K (p.Glu253Lys), rs672601369, ClinGen CA212633, cosmic curated COSV10813, ClinVar RCV000149481, REVEL 0.95, CADD 26.30, Pathogenic, Early-infantile developmental and epileptic encephalopathy; KIF1A-related disord
- R254P (p.Arg254Pro), UniProt VAR 086870, Pathogenic, not provided
- R254Q (p.Arg254Gln), UniProt VAR 083699, REVEL 0.78, CADD 26.30, Pathogenic/Likely pathogenic, Spastic paraplegia 30A, autosomal dominant; Hereditary spastic paraplegia 30; Ne
- R254W (p.Arg254Trp), UniProt VAR 083700, REVEL 0.81, CADD 29.30, Pathogenic/Likely pathogenic, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- A255V (p.Ala255Val), rs387906798, ClinGen CA351303108, ClinVar RCV002877610, ClinVar RCV003320393, REVEL 0.81, CADD 27.60, Pathogenic, Spastic paraplegia 30B, autosomal recessive
- T258M (p.Thr258Met), UniProt VAR 083701, REVEL 0.79, CADD 25.40, Pathogenic/Likely pathogenic, Hereditary spastic paraplegia; Neuropathy, hereditary sensory, type 2C; Heredita
- G262V (p.Gly262Val), rs2538276835, ClinGen CA351302919, ClinVar RCV002304862, NCI-TCGA TCGA novel, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- T263K (p.Thr263Lys), rs868837727, ClinGen CA351302903, ClinVar RCV003805539, AlphaMissense 0.73, MetaLR 0.44, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- R264H (p.Arg264His), rs1413440372, ClinGen CA351302879, cosmic curated COSV10884, NCI-TCGA Cosmic COSV5750, REVEL 0.76, CADD 25.20, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- E267G (p.Glu267Gly), rs2538259388, ClinGen CA351302710, ClinVar RCV003813450, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- E267Q (p.Glu267Gln), UniProt VAR 086871, Pathogenic, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- A269D (p.Ala269Asp), rs1469297168, ClinGen CA351302683, ClinVar RCV002466344, AlphaMissense 0.99, MetaLR 0.38, Likely pathogenic, Hereditary spastic paraplegia 30
- A269V (p.Ala269Val), rs1469297168, ClinGen CA351302680, ClinVar RCV003797933, gnomAD rs1469297168, REVEL 0.63, AlphaMissense 0.99, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- N272S (p.Asn272Ser), rs876661283, ClinGen CA10577247, ClinVar RCV000213797, ClinVar RCV001854764, AlphaMissense 0.88, MetaLR 0.73, Pathogenic/Likely pathogenic, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- S274L (p.Ser274Leu), rs797045655, ClinGen CA209610, NCI-TCGA Cosmic COSV5748, cosmic curated COSV57486, AlphaMissense 1.00, MetaLR 0.80, Pathogenic/Likely pathogenic, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- L275P (p.Leu275Pro), UniProt VAR 086874, Likely pathogenic, Inborn genetic diseases
- L275Q (p.Leu275Gln), rs2054279545, ClinGen CA351302603, ClinVar RCV003808958, AlphaMissense 1.00, MetaLR 0.89, Likely pathogenic, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- L278P (p.Leu278Pro), UniProt VAR 086875, Likely pathogenic, Intellectual disability, autosomal dominant 9
- G279D (p.Gly279Asp), UniProt VAR 086876, Uncertain significance, in KAND
- G279R (p.Gly279Arg), rs1473143877, ClinGen CA351302570, ClinVar RCV002462661, UniProt VAR 086877, AlphaMissense 1.00, MetaLR 0.86, Pathogenic, not provided
- K280R (p.Lys280Arg), UniProt VAR 086878, Likely pathogenic, Intellectual disability, autosomal dominant 9
- V281D (p.Val281Asp), rs2538258231, ClinGen CA351302539, ClinVar RCV002301184, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- P292A (p.Pro292Ala), rs2538238935, ClinGen CA351301561, ClinVar RCV003806255, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- P292L (p.Pro292Leu), rs2538238870, ClinGen CA351301547, ClinVar RCV003785750, REVEL 0.31, CADD 23.70, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- K296E (p.Lys296Glu), rs2537997003, ClinGen CA351297989, ClinVar RCV003805272, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- T301I (p.Thr301Ile), rs2537996681, ClinGen CA351297860, ClinVar RCV003786981, ClinVar RCV006272528, REVEL 0.18, CADD 24.40, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- P305L (p.Pro305Leu), UniProt VAR 086879, REVEL 0.93, CADD 29.40, Pathogenic/Likely pathogenic, Hereditary spastic paraplegia 30; KIF1A related neurological disorder; Neuropath
- Y306C (p.Tyr306Cys), UniProt VAR 086880, Uncertain significance, in KAND
- R307G (p.Arg307Gly), UniProt VAR 086881, Likely pathogenic, Intellectual disability, autosomal dominant 9
- R307P (p.Arg307Pro), UniProt VAR 083702, Likely pathogenic, Intellectual disability, autosomal dominant 9
- R307Q (p.Arg307Gln), rs1064793161, ClinGen CA16617510, ClinVar RCV000480291, ClinVar RCV000496175, REVEL 0.93, CADD 27.00, Pathogenic/Likely pathogenic, KIF1A-related disorder; Hereditary spastic paraplegia 30; Neuropathy, hereditary
- L311F (p.Leu311Phe), rs375492399, ClinGen CA351297697, ClinVar RCV003013239, REVEL 0.78, CADD 24.00, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- L314P (p.Leu314Pro), UniProt VAR 086882, Uncertain significance, in KAND
- R316Q (p.Arg316Gln), rs749718096, ClinGen CA16042465, NCI-TCGA Cosmic COSV1002, NCI-TCGA Cosmic COSV5748, REVEL 0.61, CADD 27.90, Conflicting interpretations, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- R316W (p.Arg316Trp), rs672601370, ClinGen CA212636, ClinVar RCV000149482, ClinVar RCV000374842, AlphaMissense 0.99, MetaLR 0.59, Pathogenic/Likely pathogenic, Inborn genetic diseases; Hereditary spastic paraplegia 30; Neuropathy, hereditar
- G320D (p.Gly320Asp), rs2537958202, ClinGen CA351297033, ClinVar RCV002298278, NCI-TCGA TCGA novel, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- G321D (p.Gly321Asp), rs2537958061, ClinGen CA351297014, ClinVar RCV003142597, REVEL 0.92, CADD 25.30, Uncertain significance, not provided
- G321S (p.Gly321Ser), rs2537958110, ClinGen CA351297017, ClinVar RCV002837480, ClinVar RCV003886585, REVEL 0.92, CADD 28.60, Conflicting interpretations, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- S323P (p.Ser323Pro), UniProt VAR 083704, Likely pathogenic, Intellectual disability, autosomal dominant 9
- R324S (p.Arg324Ser), rs2537957873, ClinGen CA351296964, ClinVar RCV002807227, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- A330D (p.Ala330Asp), rs2537957670, ClinGen CA351296847, ClinVar RCV003887598, Likely pathogenic, not provided
- P333A (p.Pro333Ala), rs2537957381, ClinGen CA351296797, ClinVar RCV003803608, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- P333S (p.Pro333Ser), rs2537957381, ClinGen CA351296793, ClinVar RCV003233389, Uncertain significance, not provided
- A334T (p.Ala334Thr), rs2537957328, ClinGen CA351296782, ClinVar RCV003322680, REVEL 0.73, CADD 26.70, Likely pathogenic, Hereditary spastic paraplegia 30
- I336V (p.Ile336Val), rs375423065, UniProt VAR 075489, ESP rs375423065, TOPMed rs375423065, REVEL 0.30, CADD 22.10
- N337S (p.Asn337Ser), rs2537957124, ClinGen CA351296721, ClinVar RCV003030716, ClinVar RCV003030717, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- Y338C (p.Tyr338Cys), rs2125976707, ClinGen CA351296704, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10024, AlphaMissense 0.98, MetaLR 0.62, Pathogenic, Hereditary spastic paraplegia 30
- D339N (p.Asp339Asn), rs2052419904, ClinGen CA351296698, NCI-TCGA Cosmic COSV1002, cosmic curated COSV10023, REVEL 0.67, CADD 24.60, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- T341I (p.Thr341Ile), rs2125976621, ClinGen CA351296667, ClinVar RCV003482751, AlphaMissense 0.98, MetaLR 0.93, Uncertain significance, not provided
- T341P (p.Thr341Pro), rs2052419658, ClinGen CA351296671, ClinVar RCV003320401, AlphaMissense 0.98, MetaLR 0.93, Likely pathogenic, Hereditary spastic paraplegia 30
- T344M (p.Thr344Met), rs2125976585, ClinGen CA351296627, cosmic curated COSV10966, ClinVar RCV002035472, AlphaMissense 0.98, MetaLR 0.83, Pathogenic, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- R350G (p.Arg350Gly), rs387907259, ClinGen CA351296358, ClinVar RCV001251223, ClinVar RCV001879817, REVEL 0.93, CADD 28.80, Likely pathogenic, Hereditary spastic paraplegia 30
- R350W (p.Arg350Trp), UniProt VAR 083705, REVEL 0.93, CADD 32.00, Likely pathogenic, not provided; Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory
- Q353R (p.Gln353Arg), rs2537929765, ClinGen CA351295851, ClinVar RCV003017347, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- R355C (p.Arg355Cys), rs1225233710, ClinGen CA351295825, NCI-TCGA Cosmic COSV5749, cosmic curated COSV57494, REVEL 0.73, CADD 28.80, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
- R355H (p.Arg355His), rs373042822, ClinGen CA2208546, cosmic curated COSV57481, ClinVar RCV000639802, REVEL 0.56, CADD 23.00, Uncertain significance, Inborn genetic diseases; not provided; Neuropathy, hereditary sensory and autono
- V359L (p.Val359Leu), rs2125969107, ClinGen CA351295755, ClinVar RCV002998871, AlphaMissense 0.06, MetaLR 0.52, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- N361S (p.Asn361Ser), rs1575603705, ClinGen CA351295670, ClinVar RCV003785952, ClinVar RCV005871309, REVEL 0.88, CADD 26.50, Uncertain significance, not provided; Neuropathy, hereditary sensory, type 2C; Hereditary spastic parapl
- N365K (p.Asn365Lys), rs2537928675, ClinGen CA351295560, ClinVar RCV003058837, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal domi
- R370H (p.Arg370His), rs1397376358, ClinGen CA351295449, NCI-TCGA Cosmic COSV5750, cosmic curated COSV57506, REVEL 0.76, AlphaMissense 0.49, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- R370P (p.Arg370Pro), rs1397376358, ClinGen CA351295448, ClinVar RCV003785712, AlphaMissense 0.49, MetaLR 0.69, Uncertain significance, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- L372V (p.Leu372Val), rs2537927812, ClinGen CA351295391, ClinVar RCV003815349, Pathogenic, Neuropathy, hereditary sensory, type 2C; Hereditary spastic paraplegia 30; Intel
- R378L (p.Arg378Leu), rs1437914316, ClinGen CA351295229, ClinVar RCV002299377, AlphaMissense 0.32, MetaLR 0.51, Uncertain significance, Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intel
Public KIF1A analysis runs
- KIF1A analysis run — KIF1A (560 variants) — completed 2026-08-20